Frequency of febrile neutropenia in breast cancer patients receiving epirubicin and docetaxel/paclitaxel with colony-stimulating growth factors: a comparison of filgrastim or lenograstim with pegfilgrastim. [electronic resource]
Producer: 20061208Description: 290-3 p. digitalISSN:- 0030-2414
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Colony-Stimulating Factors -- therapeutic use
- Docetaxel
- Epirubicin -- administration & dosage
- Female
- Fever -- epidemiology
- Filgrastim
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Humans
- Lenograstim
- Middle Aged
- Neutropenia -- chemically induced
- Paclitaxel -- administration & dosage
- Polyethylene Glycols
- Recombinant Proteins -- therapeutic use
- Taxoids -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.